UV1 Receives Orphan Drug Designation From EMA in Mesothelioma

The European Medicines Agency has granted orphan drug designation to UV1 in mesothelioma.

Related Keywords

,European Medicines Agency ,Fast Track ,Mesothelioma ,Fema ,Cancer Vaccine Uv1 ,Uv1 ,Cancer Vaccine ,Carlos De Sousa ,D ,Nba ,Phase 2 Nipu Trial ,Nct04300244 ,Orphan Drug Designation ,